![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
The 40th ICAAC was the usual great event with around 15,000 participants and numerous parallel sessions of both oral and poster presentations. The present report covers only selected topics concerning antifungal drugs. Three compounds of the triazole class (voriconazole, posaconazole and ravuconazole) and three of the candin class (caspofungin, V-echinocandin and FK-463) are currently in advanced clinical development. These compounds received extensive coverage in terms of new clinical and preclinical data as well as lectures reviewing the respective compound classes. Preclinical data were also presented for three new investigational triazoles (SSP 750, R-120758 and TAK-456). Other investigational compounds included representatives of the sordarin class. No new compound classes or antifungal targets were presented.